{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/entity/GLUE/timeline","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://api.ai-analytics.org/license","usage_info":"https://api.ai-analytics.org/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-22T11:59:12.213Z","methodology_url":"https://api.ai-analytics.org/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9676,"canonical_name":"Monte Rosa Therapeutics, Inc.","cik":"0001826457","uei":null,"lei":null,"duns":null,"ticker":"GLUE"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","open.payments","dol.form5500","hud.housing","irs.bmf"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":74},"count":74,"timeline":[{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — Monte Rosa Therapeutics, Inc. — 2026-07-17","url_slug":"/sec/cik-0001826457/4/0001193125-26-307791","accession_number":"0001193125-26-307791","importance":30},{"ts":"2026-07-16","kind":"sec.form144","reporter":"MARKUS WARMUTH","title":"Officer","shares":9500,"usd_value":220219,"security_title":"Common","approx_sale_date":"2026-07-16","accession_number":"0001950047-26-007144","importance":40.04404371},{"ts":"2026-07-16","kind":"sec.insider.s","reporter":"Warmuth Markus","title":"President & CEO","shares":9500,"price_per_share":23.1809,"usd_value":220219,"security_title":"Common Stock","importance":35.22021855},{"ts":"2026-07-16","kind":"sec.filing","form_type":"144","title":"144 — Monte Rosa Therapeutics, Inc. — 2026-07-16","url_slug":"/sec/cik-0001826457/144/0001950047-26-007144","accession_number":"0001950047-26-007144","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"4","title":"4 — Monte Rosa Therapeutics, Inc. — 2026-07-16","url_slug":"/sec/cik-0001826457/4/0001193125-26-306110","accession_number":"0001193125-26-306110","importance":30},{"ts":"2026-07-15","kind":"sec.form144","reporter":"Champoux Jennifer","title":"Officer","shares":4351,"usd_value":101730,"security_title":"Common","approx_sale_date":"2026-07-15","accession_number":"0001969223-26-000786","importance":40.020345972},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"Champoux Jennifer","title":"Chief Operating Officer","shares":4351,"price_per_share":23.3808,"usd_value":101730,"security_title":"Common Stock","importance":35.1017298608},{"ts":"2026-07-15","kind":"sec.filing","form_type":"144","title":"144 — Monte Rosa Therapeutics, Inc. — 2026-07-15","url_slug":"/sec/cik-0001826457/144/0001969223-26-000786","accession_number":"0001969223-26-000786","importance":30},{"ts":"2026-07-15","kind":"sec.insider.m","reporter":"Champoux Jennifer","title":"Chief Operating Officer","shares":4351,"price_per_share":3.98,"usd_value":17317,"security_title":"Common Stock","importance":15.01731698},{"ts":"2026-07-08","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Monte Rosa Therapeutics, Inc. — 2026-07-08","url_slug":"/sec/cik-0001826457/schedule-13g-a/0000080255-26-000442","accession_number":"0000080255-26-000442","importance":30},{"ts":"2026-07-07","kind":"sec.filing","form_type":"4","title":"4 — Monte Rosa Therapeutics, Inc. — 2026-07-07","url_slug":"/sec/cik-0001826457/4/0001193125-26-297558","accession_number":"0001193125-26-297558","importance":30},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Townson Sharon","title":"Chief Scientific Officer","shares":5600,"price_per_share":23.2495,"usd_value":130197,"security_title":"Common Stock","importance":35.1301972},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Townson Sharon","title":"Chief Scientific Officer","shares":400,"price_per_share":24.13,"usd_value":9652,"security_title":"Common Stock","importance":35.009652},{"ts":"2026-07-06","kind":"sec.insider.m","reporter":"Townson Sharon","title":"Chief Scientific Officer","shares":6000,"price_per_share":6.14,"usd_value":36840,"security_title":"Common Stock","importance":15.03684},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — Monte Rosa Therapeutics, Inc. — 2026-07-01","url_slug":"/sec/cik-0001826457/4/0001193125-26-292767","accession_number":"0001193125-26-292767","importance":30},{"ts":"2026-07-01","kind":"sec.insider.j","reporter":"Behbahani Ali","title":null,"shares":1000000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.j","reporter":"Behbahani Ali","title":null,"shares":15000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.j","reporter":"Behbahani Ali","title":null,"shares":15000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-30","kind":"sec.form144","reporter":"FILIP JANKU","title":"Officer","shares":5407,"usd_value":129227,"security_title":"Common","approx_sale_date":"2026-06-30","accession_number":"0001950047-26-006665","importance":40.02584546},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Janku Filip","title":"Chief Medical Officer","shares":5407,"price_per_share":24.5,"usd_value":132472,"security_title":"Common Stock","importance":35.1324715},{"ts":"2026-06-30","kind":"sec.filing","form_type":"144","title":"144 — Monte Rosa Therapeutics, Inc. — 2026-06-30","url_slug":"/sec/cik-0001826457/144/0001950047-26-006665","accession_number":"0001950047-26-006665","importance":30},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — Monte Rosa Therapeutics, Inc. — 2026-06-30","url_slug":"/sec/cik-0001826457/4/0001193125-26-290486","accession_number":"0001193125-26-290486","importance":30},{"ts":"2026-06-30","kind":"sec.insider.m","reporter":"Janku Filip","title":"Chief Medical Officer","shares":5407,"price_per_share":13.41,"usd_value":72508,"security_title":"Common Stock","importance":15.07250787},{"ts":"2026-06-29","kind":"sec.form144","reporter":"ANTHONY M MANNING","title":"Director","shares":10000,"usd_value":231100,"security_title":"Common","approx_sale_date":"2026-06-29","accession_number":"0001950047-26-006574","importance":40.04622},{"ts":"2026-06-29","kind":"sec.form144","reporter":"FILIP JANKU","title":"Officer","shares":6000,"usd_value":133740,"security_title":"Common","approx_sale_date":"2026-06-29","accession_number":"0001950047-26-006612","importance":40.026748},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Manning Anthony M.","title":null,"shares":10000,"price_per_share":23.11,"usd_value":231100,"security_title":"Common Stock","importance":35.2311},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Janku Filip","title":"Chief Medical Officer","shares":6000,"price_per_share":22.95,"usd_value":137700,"security_title":"Common Stock","importance":35.1377},{"ts":"2026-06-29","kind":"sec.filing","form_type":"144","title":"144 — Monte Rosa Therapeutics, Inc. — 2026-06-29","url_slug":"/sec/cik-0001826457/144/0001950047-26-006612","accession_number":"0001950047-26-006612","importance":30},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Janku Filip","title":"Chief Medical Officer","shares":6000,"price_per_share":7.56,"usd_value":45360,"security_title":"Common Stock","importance":15.04536},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Manning Anthony M.","title":null,"shares":10000,"price_per_share":4.16,"usd_value":41600,"security_title":"Common Stock","importance":15.0416},{"ts":"2026-06-25","kind":"sec.filing","form_type":"4","title":"4 — Monte Rosa Therapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001826457/4/0001193125-26-282735","accession_number":"0001193125-26-282735","importance":30},{"ts":"2026-06-25","kind":"sec.filing","form_type":"4","title":"4 — Monte Rosa Therapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001826457/4/0001193125-26-282736","accession_number":"0001193125-26-282736","importance":30},{"ts":"2026-06-25","kind":"sec.filing","form_type":"4","title":"4 — Monte Rosa Therapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001826457/4/0001193125-26-282740","accession_number":"0001193125-26-282740","importance":30},{"ts":"2026-06-24","kind":"sec.form144","reporter":"FILIP JANKU","title":"Officer","shares":30000,"usd_value":621300,"security_title":"Common","approx_sale_date":"2026-06-24","accession_number":"0001950047-26-006456","importance":40.12426},{"ts":"2026-06-24","kind":"sec.insider.s","reporter":"Janku Filip","title":"Chief Medical Officer","shares":30000,"price_per_share":21.4227,"usd_value":642681,"security_title":"Common Stock","importance":35.642681},{"ts":"2026-06-24","kind":"sec.filing","form_type":"144","title":"144 — Monte Rosa Therapeutics, Inc. — 2026-06-24","url_slug":"/sec/cik-0001826457/144/0001950047-26-006456","accession_number":"0001950047-26-006456","importance":30},{"ts":"2026-06-24","kind":"sec.insider.m","reporter":"Janku Filip","title":"Chief Medical Officer","shares":30000,"price_per_share":7.56,"usd_value":226800,"security_title":"Common Stock","importance":15.2268},{"ts":"2026-06-23","kind":"sec.form144","reporter":"EDMUND DUNN","title":"Officer","shares":16665,"usd_value":344986,"security_title":"Common","approx_sale_date":"2026-06-23","accession_number":"0001950047-26-006406","importance":40.0689971},{"ts":"2026-06-23","kind":"sec.form144","reporter":"FILIP JANKU","title":"Officer","shares":11845,"usd_value":221146,"security_title":"Common","approx_sale_date":"2026-06-23","accession_number":"0001950047-26-006428","importance":40.04422923},{"ts":"2026-06-23","kind":"sec.form144","reporter":"Champoux Jennifer","title":"Officer","shares":2175,"usd_value":40042,"security_title":"Common","approx_sale_date":"2026-06-23","accession_number":"0001969223-26-000720","importance":40.00800835},{"ts":"2026-06-23","kind":"sec.insider.s","reporter":"Janku Filip","title":"Chief Medical Officer","shares":11845,"price_per_share":20.2214,"usd_value":239522,"security_title":"Common Stock","importance":35.239522483},{"ts":"2026-06-23","kind":"sec.insider.s","reporter":"Townson Sharon","title":"Chief Scientific Officer","shares":3000,"price_per_share":20,"usd_value":60000,"security_title":"Common Stock","importance":35.06},{"ts":"2026-06-23","kind":"sec.insider.s","reporter":"Champoux Jennifer","title":"Chief Operating Officer","shares":2175,"price_per_share":20,"usd_value":43500,"security_title":"Common Stock","importance":35.0435},{"ts":"2026-06-23","kind":"sec.filing","form_type":"144","title":"144 — Monte Rosa Therapeutics, Inc. — 2026-06-23","url_slug":"/sec/cik-0001826457/144/0001950047-26-006406","accession_number":"0001950047-26-006406","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"144","title":"144 — Monte Rosa Therapeutics, Inc. — 2026-06-23","url_slug":"/sec/cik-0001826457/144/0001950047-26-006428","accession_number":"0001950047-26-006428","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"144","title":"144 — Monte Rosa Therapeutics, Inc. — 2026-06-23","url_slug":"/sec/cik-0001826457/144/0001969223-26-000720","accession_number":"0001969223-26-000720","importance":30},{"ts":"2026-06-23","kind":"sec.insider.m","reporter":"Janku Filip","title":"Chief Medical Officer","shares":6000,"price_per_share":7.56,"usd_value":45360,"security_title":"Common Stock","importance":15.04536},{"ts":"2026-06-23","kind":"sec.insider.m","reporter":"Townson Sharon","title":"Chief Scientific Officer","shares":3000,"price_per_share":6.14,"usd_value":18420,"security_title":"Common Stock","importance":15.01842},{"ts":"2026-06-23","kind":"sec.insider.m","reporter":"Champoux Jennifer","title":"Chief Operating Officer","shares":2175,"price_per_share":3.98,"usd_value":8657,"security_title":"Common Stock","importance":15.0086565},{"ts":"2026-06-18","kind":"sec.filing","form_type":"4","title":"4 — Monte Rosa Therapeutics, Inc. — 2026-06-18","url_slug":"/sec/cik-0001826457/4/0001193125-26-275805","accession_number":"0001193125-26-275805","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"4","title":"4 — Monte Rosa Therapeutics, Inc. — 2026-06-18","url_slug":"/sec/cik-0001826457/4/0001193125-26-275806","accession_number":"0001193125-26-275806","importance":30},{"ts":"2026-06-17","kind":"sec.form144","reporter":"Champoux Jennifer","title":"Officer","shares":2176,"usd_value":39005,"security_title":"Common","approx_sale_date":"2026-06-17","accession_number":"0001969223-26-000711","importance":40.00780096},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Townson Sharon","title":"Chief Scientific Officer","shares":3000,"price_per_share":19,"usd_value":57000,"security_title":"Common Stock","importance":35.057},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Champoux Jennifer","title":"Chief Operating Officer","shares":2176,"price_per_share":19,"usd_value":41344,"security_title":"Common Stock","importance":35.041344},{"ts":"2026-06-17","kind":"sec.filing","form_type":"144","title":"144 — Monte Rosa Therapeutics, Inc. — 2026-06-17","url_slug":"/sec/cik-0001826457/144/0001969223-26-000711","accession_number":"0001969223-26-000711","importance":30},{"ts":"2026-06-17","kind":"sec.insider.m","reporter":"Townson Sharon","title":"Chief Scientific Officer","shares":3000,"price_per_share":6.14,"usd_value":18420,"security_title":"Common Stock","importance":15.01842},{"ts":"2026-06-17","kind":"sec.insider.m","reporter":"Champoux Jennifer","title":"Chief Operating Officer","shares":2176,"price_per_share":3.98,"usd_value":8660,"security_title":"Common Stock","importance":15.00866048},{"ts":"2026-06-12","kind":"sec.filing","form_type":"4","title":"4 — SCHIFF ANDREW N — 2026-06-12","url_slug":"/sec/cik-0001172252/4/0001193125-26-269365","accession_number":"0001193125-26-269365","importance":30},{"ts":"2026-06-12","kind":"sec.filing","form_type":"4","title":"4 — Monte Rosa Therapeutics, Inc. — 2026-06-12","url_slug":"/sec/cik-0001826457/4/0001193125-26-269348","accession_number":"0001193125-26-269348","importance":30},{"ts":"2026-06-12","kind":"sec.filing","form_type":"4","title":"4 — Monte Rosa Therapeutics, Inc. — 2026-06-12","url_slug":"/sec/cik-0001826457/4/0001193125-26-269378","accession_number":"0001193125-26-269378","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Monte Rosa Therapeutics, Inc. — 2026-06-11","url_slug":"/sec/cik-0001826457/8-k/0001193125-26-267465","accession_number":"0001193125-26-267465","importance":35},{"ts":"2026-06-02","kind":"sec.form144","reporter":"Warmuth Markus","title":"Officer","shares":5467,"usd_value":103447,"security_title":"Common","approx_sale_date":"2026-05-01","accession_number":"0001965301-26-000067","importance":40.020689326},{"ts":"2026-06-02","kind":"sec.filing","form_type":"144/A","title":"144/A — Monte Rosa Therapeutics, Inc. — 2026-06-02","url_slug":"/sec/cik-0001826457/144-a/0001965301-26-000067","accession_number":"0001965301-26-000067","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — Monte Rosa Therapeutics, Inc. — 2026-06-02","url_slug":"/sec/cik-0001826457/4/0001193125-26-253472","accession_number":"0001193125-26-253472","importance":30},{"ts":"2026-06-01","kind":"sec.form144","reporter":"Warmuth Markus","title":"Officer","shares":5466,"usd_value":106253,"security_title":"Common","approx_sale_date":"2026-06-01","accession_number":"0001965301-26-000066","importance":40.021250606},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Warmuth Markus","title":"President & CEO","shares":4998,"price_per_share":19.412,"usd_value":97021,"security_title":"Common Stock","importance":35.097021176},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Warmuth Markus","title":"President & CEO","shares":468,"price_per_share":19.7262,"usd_value":9232,"security_title":"Common Stock","importance":35.0092318616},{"ts":"2026-06-01","kind":"sec.filing","form_type":"144","title":"144 — Monte Rosa Therapeutics, Inc. — 2026-06-01","url_slug":"/sec/cik-0001826457/144/0001965301-26-000066","accession_number":"0001965301-26-000066","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Monte Rosa Therapeutics, Inc. — 2026-06-01","url_slug":"/sec/cik-0001826457/4/0001193125-26-251395","accession_number":"0001193125-26-251395","importance":30},{"ts":"2026-05-29","kind":"sec.insider.s","reporter":"Townson Sharon","title":"Chief Scientific Officer","shares":6000,"price_per_share":19.87,"usd_value":119220,"security_title":"Common Stock","importance":35.11922},{"ts":"2026-05-29","kind":"sec.insider.m","reporter":"Townson Sharon","title":"Chief Scientific Officer","shares":6000,"price_per_share":6.14,"usd_value":36840,"security_title":"Common Stock","importance":15.03684},{"ts":"2026-05-21","kind":"sec.form144","reporter":"ANTHONY M MANNING","title":"Director","shares":10000,"usd_value":180100,"security_title":"Common","approx_sale_date":"2026-05-21","accession_number":"0001950047-26-004881","importance":40.03602},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Monte Rosa Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001826457/schedule-13g-a/0000921895-26-001394","accession_number":"0000921895-26-001394","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Monte Rosa Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001826457/schedule-13g-a/0001193125-26-226862","accession_number":"0001193125-26-226862","importance":30}]}